Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.

The Prostate - 1 Sept 2002

Shibata Atsuko, Garcia Maria Isabel, Cheng Iona, Stamey Thomas A, McNeal John E, Brooks James D, Henderson Stavonnie, Yemoto Cheryl E, Peehl Donna M

Abstract excerpt

BACKGROUND: Cytosine-adenine-guanine repeat length of the androgen receptor gene and the A49T and V89L polymorphisms of the 5 alpha-reductase (SRD5A2) gene have been associated with prostate cancer. METHODS: We investigated the relationship of the three genetic polymorphisms to tumor grade among 211 men who had undergone radical prostatectomy. Subjects had prostate cancer <3 cm(3) with a percentage of cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Longitudinal Studies

Share to Oxidoreductases

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 12210487
DOI: 10.1002/pros.10119

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.PMID 12210487Read ↗

Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.Semantic proximity Read ↗

Association of SRD5A2 genotype and pathological characteristics of prostate tumors.Semantic proximity Read ↗

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.Semantic proximity Read ↗

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.Semantic proximity Read ↗

Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.Semantic proximity Read ↗

SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.Semantic proximity Read ↗

Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Semantic proximity Read ↗

[V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].Semantic proximity Read ↗

SRD5A polymorphisms and biochemical failure after radical prostatectomy.Semantic proximity Read ↗

SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.